Pathogenesis, Clinical Picture and Treatment of von Willebrand's Disease
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 27 (6) , 641-651
- https://doi.org/10.3109/07853899509019250
Abstract
Von Willebrand's disease Is probably the most common congenital bleeding disorder, with a prevalence close to 1% in some epidemiological studies. The disease is caused by a quantitative deficiency or a qualitative defect of the von Willebrand factor, which is a multimeric glycoprotein consisting of subunits of 2050 amino acids. The size of multimers ranges from approximately 500 kDa to 20 MDa. Each subunit consist of repeated domain structures. Several functional domains have been identified which can bind such structures as platelet receptors glycoprotein lb or llb/IIIA, heparin, collagen or factor VIII. The von Willebrand factor has two main functions in haemostasis, to promote normal platelet adhesion and to be a carrier protein for factor VIII. Von Willebrand's disease is divided into three major types and several subtypes depending on the quantity and quality of the von Willebrand factor in plasma and platelets. A new classification has recently been proposed. Typical symptoms are mucosal bleeding, easy bruising and increased bleeding tendency in connection with tooth extractions and other invasive procedures. Severe cases may have joint bleeding and other haemophilia-like bleeding. Desmopressin is the treatment of choice in mild cases, whereas more severe cases need treatment with factor VIII concentrates.Keywords
This publication has 94 references indexed in Scilit:
- Prevalence of von Willebrand disease in children: A multiethnic studyThe Journal of Pediatrics, 1993
- Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type IIIAnnals of Hematology, 1992
- Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetinBiochemistry, 1992
- Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type IAnnals of Hematology, 1990
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- The size of human factor VIII heterodimers and the effects produced by thrombinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's DiseaseNew England Journal of Medicine, 1983
- Pseudo-von Willebrand's DiseaseNew England Journal of Medicine, 1982
- Heightened Interaction between Platelets and Factor VIII/von Willebrand Factor in a New Subtype of von Willebrand's DiseaseNew England Journal of Medicine, 1980
- v. Willebrand's Disease and its Correction with Human Plasma Fraction 1‐0Acta Medica Scandinavica, 1957